Healthcare >> Analyst Interviews >> February 20, 2015
M&A in Med Tech Space a Healthy Progression for the Industry
Joanne K. Wuensch is a Research Analyst in the equity research group at BMO Capital Markets Corp., where she covers medical technology companies in the cardiology, ophthalmology, orthopedic and respiratory sectors. Before joining BMO Capital Markets, she was a Research Analyst with ABN Amro Group, formerly ING Barings, where she covered medical products, as well as a Research Associate in the medical technology group at UBS Securities. Her career in financial services began at J.P. Morgan, where, among other positions, she was an Associate in municipal finance investment banking in the health care and higher education group. Ms. Wuensch joined BMO Capital Markets in 2002. She holds an MPA degree from New York University and a B.A. from the University of Delaware. Profile
TWST: What is your coverage?
Ms. Wuensch: I cover the medical technology space. That includes orthopedic and cardiovascular companies, as well as the larger diversified